Fluoropyrimidine-based adjuvant chemotherapy in patients with resected biliary tract cancers.

被引：0
|
作者：
Go, Se-il
Kang, Jung Hun
Jeong, Chi-Young
Lee, Gyeong-won
Kim, Hoon-Gu
Kang, Myoung-Hee
Song, Haa-na
机构：
[1] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Div Hematol Oncol, Dept Internal Med,Sch Med, Jinju, South Korea
[2] Gyeongsang Natl Univ Hosp, Dept Surg, Jinju, South Korea
[3] Gyeongsang Natl Univ Hosp, Div Hematol Oncol, Dept Internal Med, Jinju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15108
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
    Bum Jun Kim
    Changhoon Yoo
    Kyu-pyo Kim
    Jaewon Hyung
    Seong Joon Park
    Baek-Yeol Ryoo
    Heung-Moon Chang
    [J]. British Journal of Cancer, 2017, 116 : 561 - 567
  • [22] Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor
    Dee, Edward Christopher
    Freret, Morgan E.
    Wo, Jennifer Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 937 - 939
  • [23] ADJUVANT CHEMOTHERAPY FOR RESECTED BILIARY TRACT CANCER: A RETROSPECTIVE ANALYSIS
    Caponi, S.
    Lucchesi, M.
    Vasile, E.
    Caparello, C.
    Ginocchi, L.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 262 - 262
  • [24] Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients
    Kim, Bum Jun
    Yoo, Changhoon
    Kim, Kyu-pyo
    Hyung, Jaewon
    Park, Seong Joon
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (05) : 561 - 567
  • [25] ASO Visual Abstract: Trends in Receipt of Adjuvant Chemotherapy and Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    [J]. Annals of Surgical Oncology, 2023, 30 : 4824 - 4825
  • [26] Adjuvant chemotherapy for resected biliary tract cancers: A fluorouracil-based scheme beats out a gemcitabine-based scheme for the win
    Hu, Ya-Fei
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    [J]. HEPATOLOGY, 2024, 79 (05) : 965 - 969
  • [27] FOLFIRI in advanced biliary tract cancers.
    Mizrahi, Jonathan
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phani Keerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [28] Adjuvant chemotherapy for resected biliary tract cancer: A retrospective analysis.
    Lucchesi, M.
    Vasile, E.
    Lencioni, M.
    Caparello, C.
    Caponi, S.
    Ginocchi, L.
    Boggi, U.
    Mosca, F.
    Filipponi, F.
    Seccia, M.
    Chiarugi, M.
    Andreuccetti, M.
    Ricci, S.
    Falcone, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
    Marta Bonet Beltrán
    Arnaud D Roth
    Gilles Mentha
    Abdelkarim S Allal
    [J]. BMC Cancer, 11
  • [30] ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers—Does One Size Fit All?
    Kristen E. Rhodin
    Michael E. Lidsky
    [J]. Annals of Surgical Oncology, 2023, 30 : 4822 - 4823
12345